On December 3, an FDA advisory panel recommended the expansion of the use of Allergan’s Lap-Band™ system for weight reduction in patients with a BMI of at least 35 kg/m2 or a BMI of at least 30 kg/m2 with one or more comorbid conditions. The panel voted 8 to 2 that the benefits of Lap-Band™ surgery were greater than the risks in patients in the new, lower weight range. While the FDA must still make the final decision, the agency usually agrees with its advisory committees.
Dr. Simpson was one of 30 weight loss surgeons involved in the study. In fact, Dr. Simpson was the only Phoenix weight loss surgeon selected to participate. Read more about this exciting new development regarding FDA approval of lower BMI guidelines for the Allergan Lap-Band.™